Latest NHS waiting list figures show that 4.95 million people are currently waiting for elective surgery
Latest NHS waiting list figures show that 4.95 million people are currently waiting for elective surgery
In Phase III, adjuvant treatment with Tagrisso reduced the risk of disease recurrence or death by 80% in the overall population
New patient-reported outcomes data also shows Erleada did not worsen side effect burden
Strategy “marks a shift away from organisations and towards service improvement”
Once-daily treatment has been approved for the management of heavy menstrual bleeding
The study will include more than 35,000 volunteers aged 18 years and older
The 2021 Communications Awards have expanded to include two brand new medical affairs categories.
Digital health company said it would use the latest funding to research and identify new areas of help and develop its platform further
Scheme will enable Roche’s supply chain partners to purchase 100% renewable energy
Once-daily oral treatment was well-tolerated and demonstrated a good safety profile in Phase IIb study
Phase II/III TeenCOVE study met primary endpoint of non-inferior immunogenicity versus adult comparator group
The 2021 Marketer of the Year competition has an avenue for all job roles and experience levels within pharma marketing.
Find out which individuals and teams have earned their spot in the head-to-head virtual finals day.
The updated draft guidance comes following recent research comparing induction times
CHMP recommended EU approval for combination treatment in its May decisions